ÂÜÀòÂÒÂ×

Ms. Ellie McGuire currently serves on the Boards of Satellite Bio, Candesant Biomedical, Montis Biosciences and Mellitus. She was also the founding President of Volastra Therapeutics.

She is an expert in residence for the Harvard Office of Technology Development and is on the Fred Hutch Evergreen Fund Advisory Committee.

Prior to co-founding the Polaris Innovation Fund, McGuire was the Head of Business Development at Lyndra, where she was a member of the founding team.

She previously held leadership and consulting positions in business development, operations and strategy in multiple life science companies including Arsia Therapeutics, Lyndra and XTuit Pharmaceuticals.